TEAT SEAL NON ANTIBIOTIC 2.6 G INTRAMAMMARY SUSPENSION, DRY COW
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
03-04-2015
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
BISMUTH SUBNITRATE
Available from:
Cross Vetpharm Group Limited
ATC code:
QG52X
INN (International Name):
BISMUTH SUBNITRATE
Dosage:
2.6 Grams
Pharmaceutical form:
Intramammary Infusion
Prescription type:
LM-Licensed Merchant
Therapeutic group:
Bovine
Therapeutic area:
VARIOUS PRODUCTS FOR TEATS AND UDDER
Therapeutic indications:
Miscellaneous
Authorization status:
Authorised
Authorization date:
2002-09-13
Summary of Product characteristics
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Teat Seal Non Antibiotic 2.6 g Intramammary suspension, Dry Cow
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Active Substance
Bismuth subnitrate
2.6g per 4g syringe
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Intramammary suspension.
Greyish white, smooth oily suspension
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dairy cows at the end of lactation.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
The veterinary medicinal product is indicated for the prevention of new intramammary infections throughout the dry
period. This results in a reduction in the incidence of subclinical mastitis in cows at calving, and of clinical mastitis in
the dry period and the subsequent lactation (for at least 60 days after calving).
4.3 CONTRAINDICATIONS
Do not use in the lactating cow.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Not intended for use in cows with suspected or confirmed mastitis at drying off. If a sealed quarter develops clinical
mastitis the affected quarter should be stripped out manually before appropriate antibacterial therapy is instituted.
It is recommended that the veterinary medicinal product be used as part of a herd approach to dry cow management
and mastitis control. Cows considered likely to be free of subclinical mastitis should be given the veterinary medicinal
product at drying off according to the criteria below. Other animals should be managed in accordance with an
approved mastitis control plan or specific veterinary advice.
For practical purposes, selection criteria may be based on the mastitis and cell count history of individual cows, or
recognised tests for the detection of
Read the complete document
